Nektar Therapeutics | NKTR - Операционный доход





Операционный доход Изменить Дата
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -65.93M 17.65M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 4.61B 777M 2026-06
Baxter International USD 276M 210M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cipla INR 8.88B 2.74B 2026-06
Dr.Reddys Laboratories INR 3.25B 2.36B 2026-06
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Exelixis USD 248.41M 2.93M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -33.44M 21.34M 2026-03
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.75B 515M 2026-06
Pfizer USD 667M 4.32B 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Takeda JPY 201.42B 215.04B 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Xencor USD -36.6M 41.26M 2026-06